Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies*

Sasano, Hironobu, Harada, Nobuhiro · 1998 · Endocrine Reviews

Abstract

I. Introduction II. Aromatase Cytochrome P450 and in Situ Estrogen Production III. Aromatase in Breast Cancer A. Introduction B. Localization C. Genetic regulation D. Clinical and pathological correlation E. Male breast cancer IV. Aromatase in Endometrial Cancer A. Introduction B. Localization C. Genetic regulation D. Clinical and pathological correlation V. Aromatase in Ovarian Cancer A. Introduction B. Localization C. Genetic regulation D. Clinical and pathological correlation VI. Summary BIOLOGICALLY active steroids are produced and secreted in the endocrine organs, such as ovary, testis, and adrenal cortex, are transported through circulation, and act on their target tissues in which their specific nuclear receptors are present. Therefore, various biological features of steroid hormone-dependent target tissues are influenced by serum or plasma concentrations of these hormones. In the great majority of human breast and endometrioid endometrial cancers and in some ovarian cancers, estrogens, especially 17β-estradiol (E2), a biologically potent estrogen, have been shown to contribute greatly to the growth and development of these neoplasms; indeed, some of these cancers actually require estrogen for their continued growth (1). Therefore, these cancers are considered to be estrogen-dependent neoplasms. In women, estradiol originates from different sources. In premenopausal women, the ovary is the main source of circulating estrogens. However, after menopause, estrogens are produced through conversion of androgens of both adrenal and ovarian origin (2). The conversion of androgens to estrone has been shown to occur principally in peripheral tissues, including skin (3), muscle (4), fat (4), and bone (5). This conversion is catalyzed by the aromatase enzyme complex. Most of the estrone formed by aromatase in these peripheral tissues is then converted into estrone sulfate by estrone sulfotransferase, which is also present in these peripheral tissues (6). Estrone sulfate may act as a reservoir of estrone formation through estrone sulfatase, i.e., estrone sulfatase plays important roles in regulating the in situ availability of estrone in various peripheral tissues (7, 8). Estrone is subsequently reduced to 17β-estradiol by 17β-hydroxysteroid dehydrogenase (HSD) type I, which is also widely distributed in various peripheral tissues (9–11). Therefore, each of these enzymes is considered to play an important role in peripheral conversion of serum androgens to 17β-estradiol but aromatization of androgens, which catalyzes the initial reaction of these conversion pathways, is generally considered to be the rate-limiting, or the most important, step of the pathway. Increased peripheral conversion of androgens to estrogens may result in elevated serum levels of estrogens. Therefore, numerous studies have been performed to study the subtle differences of serum estrogen concentrations and metabolism, which are derived from ovarian granulosa cells (12, 13), or peripheral tissues, as listed above in patients with sex steroid-dependent neoplasms. In breast cancer, several epidemiological studies indicate that plasma estradiol, adrenal androgens, and testosterone levels are higher in women who develop neoplasms over a period of several years than in those who do not (14–16). In particular, Berrino et al. (16) reported that high serum testosterone levels precede breast cancer occurrence. However, results of other studies (17, 18) were not necessarily consistent with those above. There has been no consistent evidence of increased serum estrogen concentrations or other systemic estrogen abnormalities reported in women with epithelial-stromal ovarian cancer (19–21) and endometrioid endometrial cancer (20, 22). Miller et al. (23) and Perel et al. (24) independently demonstrated that human breast and its neoplasms can produce 17β-estradiol in vitro. In addition, Reed et al. (25) directly demonstrated in situ estrogen synthesis in normal breast and breast tumor using an isotopic infusion technique. There was controversy as to whether aromatase and other enzymes involved in in situ estrogen production of human breast cancer can provide sufficient amounts of estrogens to stimulate tumor growth or exert various biological effects when these findings were first reported (26). Thorsen et al. (27) and van Landeghem et al. (28) subsequently demonstrated that the tissue concentrations of 17β-estradiol in specimens of breast cancers from postmenopausal subjects were more than 10-fold higher than those in plasma. It is true, however, that the presence of aromatase in breast cancer tissue does not mean that aromatase is present in sufficient quantity to be biologically relevant and that the presence of high estradiol concentration does not necessarily indicate that the estrogen is made in tissue, since the possibility of enhanced uptake from plasma cannot be completely ruled out. However, very recently, Yue et al. demonstrated that in situ syn

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.19.5.0342

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 222

Metadata

Authors
Sasano, H., & Harada, N.
Venue
Endocrine Reviews
Published
1998-10-01
Volume
19
Issue
5
Pages
593-607
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2144667889
Cited by
222
References
13
FWCI
4.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies*. https://app.cochat.ai/papers/10.1210/edrv.19.5.0342
The paper
Sasano, H., & Harada, N. (1998). Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies*. Endocrine Reviews. https://doi.org/10.1210/edrv.19.5.0342

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.